| Entry |
|
| Name |
Incontinentia pigmenti |
| Description |
Incontinentia pigmenti (IP) is an X-linked dominant genodermatosis mostly affecting females. Cutaneous manifestations are present along the lines of Blaschko and are subdivided into four stages: vesicular, verrucous, hyperpigmented, and atrophic. Other tissues of ectodermal origin are also affected, showing hair abnormalities, dental anomalies, and ophthalmologic and neurologic alterations. Familial incontinentia pigmenti is caused by mutations in the NEMO gene.
|
| Category |
Congenital malformation
|
| Brite |
Human diseases in ICD-11 classification [BR:br08403]
20 Developmental anomalies
Multiple developmental anomalies or syndromes
LD27 Syndromes with skin or mucosal anomalies as a major feature
H00645 Incontinentia pigmenti
Pathway-based classification of diseases [BR:br08402]
Signal transduction
nt06516 TNF signaling
H00645 Incontinentia pigmenti
|
| Pathway |
| hsa04660 | T cell receptor signaling pathway |
| hsa04662 | B cell receptor signaling pathway |
| hsa04920 | Adipocytokine signaling pathway |
|
| Network |
|
| Gene |
|
| Other DBs |
|
| Reference |
|
| Authors |
Jabbari A, Ralston J, Schaffer JV |
| Title |
Incontinentia pigmenti. |
| Journal |
Dermatol Online J 16:9 (2010) |
| Reference |
|
| Authors |
Berlin AL, Paller AS, Chan LS |
| Title |
Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. |
| Journal |
|
| Reference |
|
| Authors |
Bruckner AL |
| Title |
Incontinentia pigmenti: a window to the role of NF-kappaB function. |
| Journal |
|